YD Bio LtdYDES
▲ PositiveCapitalrelevance
Revenue up 325% and swing to net income of $6.7M from a loss.
Impact on stocks 1
Biotech & Genomic Medicine
YD Bio LtdYD Bio Limited reported unaudited financial results for the six months ended June 30, 2026, showing revenue of $0.85 million, a 325.0% increase year-over-year. The company achieved net income of $6.7 million, compared to a net loss of $1.9 million in the same period last year. As of June 30, 2026, cash stood at $2,662,004, down from $6,007,615 at the end of 2025.
YD Bio LtdRevenue up 325% and swing to net income of $6.7M from a loss.